Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
3.1
4.71
|
Price Target |
|
We'll email you a reminder when the closing price reaches BRL.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one HAPV3 stock under the Base Case scenario is 4.91 BRL. Compared to the current market price of 3.1 BRL, Hapvida Participacoes e Investimentos SA is Undervalued by 37%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Hapvida Participacoes e Investimentos SA
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for HAPV3 cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Hapvida Participacoes e Investimentos SA
Balance Sheet Decomposition
Hapvida Participacoes e Investimentos SA
Current Assets | 10.1B |
Cash & Short-Term Investments | 7.8B |
Receivables | 1.5B |
Other Current Assets | 841.2m |
Non-Current Assets | 64.1B |
Long-Term Investments | 558.1m |
PP&E | 6.8B |
Intangibles | 49.9B |
Other Non-Current Assets | 6.9B |
Current Liabilities | 7.3B |
Accounts Payable | 350.6m |
Accrued Liabilities | 1.3B |
Other Current Liabilities | 5.6B |
Non-Current Liabilities | 18.2B |
Long-Term Debt | 13.3B |
Other Non-Current Liabilities | 4.8B |
Earnings Waterfall
Hapvida Participacoes e Investimentos SA
Revenue
|
15.6B
BRL
|
Cost of Revenue
|
-10.7B
BRL
|
Gross Profit
|
4.9B
BRL
|
Operating Expenses
|
-3.8B
BRL
|
Operating Income
|
1.1B
BRL
|
Other Expenses
|
-1.6B
BRL
|
Net Income
|
-551.9m
BRL
|
Free Cash Flow Analysis
Hapvida Participacoes e Investimentos SA
BRL | |
Free Cash Flow | BRL |
In Q2 2024, our net revenue increased by 4.5% year-over-year, driven by a 9% rise in healthcare plan tickets. Despite a seasonal influx, our margins improved significantly. Adjusted EBITDA soared nearly 60% from the prior year, while adjusted net income rose 121%. We raised BRL 1 billion via debentures, optimizing our capital structure. Our verticalization rate reached 82% in appointments, enhancing cost efficiency. Guidance for 2024 indicates continued strong cash flow and EBITDA growth, maintaining CapEx around BRL 700 million. We are expanding our own hospital network in key regions like São Paulo and Rio to secure future growth.
What is Earnings Call?
HAPV3 Profitability Score
Profitability Due Diligence
Hapvida Participacoes e Investimentos SA's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
Score
Hapvida Participacoes e Investimentos SA's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
HAPV3 Solvency Score
Solvency Due Diligence
Hapvida Participacoes e Investimentos SA's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Score
Hapvida Participacoes e Investimentos SA's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
HAPV3 Price Targets Summary
Hapvida Participacoes e Investimentos SA
According to Wall Street analysts, the average 1-year price target for HAPV3 is 6.37 BRL with a low forecast of 5.76 BRL and a high forecast of 7.35 BRL.
Dividends
Current shareholder yield for HAPV3 is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Hapvida Participações e Investimentos SA operates hospitals and clinics. The company is headquartered in Fortaleza, Ceara. The company went IPO on 2018-04-25. The firm and its subsidiaries main activities are the coverage of costs of medical, hospital and dental care of its associates, the provision of medical, hospital and dentistry services and examinations and diagnoses per image. Hapvida has different healthcare facilities such as hospitals, clinics or diagnostic imaging units. The firm operates in the Northeast of Brazil, in more than 10 states such as Alagoas, Amazonas, Bahia, Pernambuco, Rio Grande do Norte, Sergipe, among others.
Contact
IPO
Employees
Officers
The intrinsic value of one HAPV3 stock under the Base Case scenario is 4.91 BRL.
Compared to the current market price of 3.1 BRL, Hapvida Participacoes e Investimentos SA is Undervalued by 37%.